High-flow nasal cannula oxygen therapy in children:

a clinical review.

High-flow nasal cannula (HFNC) is a relatively safe and effective noninvasive ventilation method that was recently accepted as a treatment option for acute respiratory support before endotracheal intubation or invasive ventilation.

High-Flow Nasal Cannula Utilization in Pediatric Critical Care

High-flow nasal cannula (HFNC) is increasingly utilized in pediatrics, delivering humidified air and oxygen for respiratory conditions causing hypoxia and distress. In the neonatal ICU, it has been associated with better tolerance, lower complications, and lower cost.

The Impact of High-Flow Nasal Cannula Use on Patient Mortality and the Availability of Mechanical Ventilators in COVID-19.

This research document evaluates the use of high-flow nasal cannula for COVID-19 on population-level mortality and ventilator availability.

Internet of things (IoT) applications to fight against COVID-19 pandemic.

The current global challenge of COVID-19 pandemic has surpassed the provincial, radical, conceptual, spiritual, social, and pedagogical boundaries. Internet of Things (IoT) enabled healthcare system is useful for proper monitoring of COVID-19 patients, by employing an interconnected network. This technology helps to increase patient satisfaction and reduces readmission rate in the hospital.

Respiratory Care Journal. (2020) High Flow Nasal Cannula for Acute Hypoxic Respiratory Failure in COVID-19.

In the United States, limited understanding of COVID-19 pathophysiology and disease trajectory, along with fear of transmission to healthcare workers, has led to an “intubate early” approach. High flow nasal cannula (HFNC) therapy is an alternative respiratory support modality for patients with acute hypoxic respiratory failure (AHRF), and this device has been standard of care for management of AHRF in both the Intensive Care Unit (ICU) and on all general inpatient wards.

COVID-19 pneumonia successfully managed with high-flow nasal cannula in a 15-year-old boy 

We report an otherwise healthy, fully immunised 15-year-old boy who was transferred to our Pediatric intensive care unit with 4 days of fever, dry cough, increased work of breathing and impending respiratory failure. Two days prior, amoxicillin/clavulanic acid was prescribed for lower airway symptoms resembling pneumonia.